Public health impact and cost-effectiveness of rotavirus vaccination in China: Comparison between private market provision and national immunization programs

Public health impact and cost-effectiveness of rotavirus vaccination in China: Comparison between private market provision and national immunization programs

In China, progress to include the RV vaccine in the national immunization program (NIP) is slow. The only two vaccines, the Lanzhou lamb rotavirus vaccine (LLR) and Rotateq, are provided through the private market. This study aims to assess the health impact and cost-effectiveness of using three vac...

Full description

Bibliographic Details
Main Authors: Jiahao Wang, Haijun Zhang, Haonan Zhang, Hai Fang
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
diarrhea
rotavirus vaccine
economic evaluation
cost-effectiveness
vaccination
china
Online Access:http://dx.doi.org/10.1080/21645515.2022.2090162

Similar Items

Similar Items